|
ZNF844 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.04880000018071E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.50850000000003E-07 |
| Normal-vs-Stage2 |
2.447300E-04 |
| Normal-vs-Stage3 |
2.183000E-04 |
| Normal-vs-Stage4 |
1.57599999999203E-05 |
| Stage1-vs-Stage2 |
8.842800E-01 |
| Stage1-vs-Stage3 |
4.588800E-01 |
| Stage1-vs-Stage4 |
5.775900E-02 |
| Stage2-vs-Stage3 |
6.981600E-01 |
| Stage2-vs-Stage4 |
6.376100E-02 |
| Stage3-vs-Stage4 |
1.628180E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.87950000025184E-07 |
| Normal-vs-AfricanAmerican |
1.26980000003662E-06 |
| Normal-vs-Asian |
2.764300E-03 |
| Caucasian-vs-AfricanAmerican |
9.286600E-01 |
| Caucasian-vs-Asian |
3.937000E-01 |
| AfricanAmerican-vs-Asian |
2.909600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.05859998334302E-09 |
| Normal-vs-Female |
1.022320E-03 |
| Male-vs-Female |
2.505800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.52239999998238E-06 |
| Normal-vs-Extreme_Weight |
8.26459999991869E-07 |
| Normal-vs-Obese |
4.17329999999883E-05 |
| Normal-vs-Extreme_Obese |
5.877600E-03 |
| Normal_Weight-vs-Extreme_Weight |
9.675800E-01 |
| Normal_Weight-vs-Obese |
4.680400E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.758400E-01 |
| Extreme_Weight-vs-Obese |
3.924800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.682400E-01 |
| Obese-vs-Extreme_Obese |
8.871000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.06119999999199E-05 |
| Normal-vs-Age(41-60Yrs) |
5.522899999999E-05 |
| Normal-vs-Age(61-80Yrs) |
5.36940000239738E-08 |
| Normal-vs-Age(81-100Yrs) |
1.389380E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.353630E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.946580E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.848800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.609600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.687200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.793600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.55060000009522E-07 |
| Normal-VS-Type2 PRCC |
1.38730000043275E-07 |
| Normal-VS-KIRP CIMP |
9.65671986818961E-13 |
| Normal-VS-Unclassified PRCC |
3.083000E-03 |
| Type1 PRCC-VS-Type2 PRCC |
2.864200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.10880002349256E-09 |
| Type1 PRCC-VS-Unclassified PRCC |
2.585400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.51730000364748E-08 |
| Type2 PRCC-VS-Unclassified PRCC |
8.366100E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.2080000000303E-07 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.8246999445899E-09 |
| Normal-vs-N1 |
2.1407999994949E-07 |
| Normal-vs-N2 |
6.29474250501971E-12 |
| N0-vs-N1 |
2.917600E-01 |
| N0-vs-N2 |
1.50669999999797E-05 |
| N1-vs-N2 |
2.364400E-03 |
|
|
